{"blog": [], "keywords": [{"value": "Ackman, William A", "name": "persons", "rank": "1", "is_major": "Y"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Pershing Square Capital Management", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Hedge Funds", "name": "subject", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/22/business/dealbook/bill-ackman-bets-again-on-valeant-taking-a-seat-on-the-board.html", "document_type": "article", "byline": {"person": [{"middlename": "Ross", "firstname": "Andrew", "role": "reported", "rank": 1, "lastname": "SORKIN", "organization": ""}], "original": "By ANDREW ROSS SORKIN"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbWide.jpg", "legacy": {"wide": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-articleLarge.jpg", "xlargeheight": "399", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 399}, {"url": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/22/business/22db-sorkin-web1/22db-sorkin-web1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "859", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "The hedge fund manager, who made billions spotting financial fraud but missed any signs of chicanery at Valeant, is hoping to salvage his investment.", "pub_date": "2016-03-22T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "DealBook Column", "print_headline": "Many Burned by Ackman\u2019s Bold Bet", "main": "Bill Ackman Bets Again on Valeant, Taking a Seat on the Board", "content_kicker": "DealBook"}, "print_page": "1", "snippet": "The hedge fund manager, who made billions spotting financial fraud but missed any signs of chicanery at Valeant, is hoping to salvage his investment.", "_id": "56f098b438f0d82d2a6d5e23", "slideshow_credits": null, "abstract": "Andrew Ross Sorkin DealBook column faults Pershing Square Capital Management leader Bill Ackman for missing financial fraud occurring at Valeant Pharmaceuticals, which led to steep loss for investors in his hedge fund. "}